Arts

Home Arts

Todas las noticias

Arts

Feb 26, 2025

GILF Shortlisted in Catalog of Guangdong's Nationwide Trade Initiative (2025), Starting New Procurement Season in March

ZHONGSHAN,China,Feb. 25,2025-- Recently,the official website of the Department of Commerce of Guangdong Province released the Catalog of Guangdong\'s Nationwide Trade Initiative (2025). After submissi

Arts

Feb 26, 2025

ADA and IPification Partner to Revolutionize Seamless Authentication for Digital Apps

SINGAPORE,Feb. 25,2025-- ADA,a leader in data and AI-driven digital transformation and all-in-one authentication solutions,and IPification,a pioneer in seamless mobile authentication,have announced t

Arts

Feb 26, 2025

BioCity Announces its selective Endothelin Type-A Receptor Antagonist, SC0062, Met the Primary Endpoint in Diabetic Kidney Disease (DKD) in a Phase 2 trial (2-SUCCEED)

SHANGHAI,Feb. 23,2025-- BioCityBiopharma (BioCity) announced that its selective endothelin receptor type A (ETA) antagonist,SC0062,met the 12-week primary endpoint of a reduction in proteinuria in the

Arts

Feb 26, 2025

Baidu Acquires JOYY's Live Streaming Business in China

BEIJING,Feb. 25,2025-- Baidu,Inc. (NASDAQ: BIDU and HKEX: 9888 (HKD Counter) and 89888 (RMB Counter)) ("Baidu"),a leading AI company with strong Internet foundation,today announced that Baid

Arts

Feb 26, 2025

MicuRx Pharmaceutical: Contezolid Global Phase III Clinical Trial Safety and Efficacy Evaluation Endorsed by Data Monitoring Committee, Promising Prospects for Diabetic Foot Infection Treatment

Data Monitoring Committee (DMC) has completed the first safety and efficacy assessment of the global Phase III clinical trial,recommending continued progression as planned

Arts

Feb 26, 2025

Everest Medicines to Announce Full-Year 2024 Financial Results on March 26, 2025

SHANGHAI,Feb. 25,2025-- Everest Medicines (HKEX 1952.HK,"Everest",or the "Company"),a biopharmaceutical company focused on the discovery,clinical development,manufacturing and comm

1 ... 47 48 49 50 51 52 53 ... 106